What is Hemab Therapeutics Holdings, Inc.'s market cap?

Hemab Therapeutics Holdings, Inc. (COAG) has a market capitalization of $2.3B and trades on XNAS.

Where is Hemab Therapeutics Holdings, Inc. headquartered?

Hemab Therapeutics Holdings, Inc. is headquartered in United States of America. It has been publicly traded since 2026.

Hemab Therapeutics Holdings (COAG) Stock Fundamentals

Hemab Therapeutics Holdings, Inc. is a biotechnology company in the healthcare sector trading on XNAS, led by CEO Benny Sorensen, with a market cap of $2.3B.

Market cap

$2.32B+98.6%

Net income-$74.4M—

Free cash flow-$72.7M—

EPS (diluted)-$53.87—

Trailing twelve months · change vs. prior year

Earnings

Q2 2026 report

May 21, 2026

EPS-$23.98Miss by $0.73

Read the full report

Next report

Aug 20, 2026 (In 1 week)

EPS estimate-$0.73

Financials

Q2 2026

Income statement

See full

Operating income-$26.1M-62.4%

Net income-$24.2M-97.8%

EPS (diluted)-$0.80+93.8%

Balance sheet

See full

Cash & equivalents$237.4M—

Total debt$1.0M—

Total equity$454.3M+421%

Total assets$467.8M—

Cash flow

See full

Operating cash flow-$22.6M-47.6%

CapEx$23.0K—

Free cash flow-$22.7M-47.8%

Valuation & ratios

Valuation

See full

Market cap$2.32B+98.6%

Enterprise value$2.08B—

Returns & leverage

See full

Debt / equity0×—

Current ratio35.8×—

Profile

CountryUnited States of America

Listed2026

CEOBenny Sorensen

SectorHealthcare

IndustryBiotechnology

Websitehemab.com

FilingsSEC EDGAR

FAQ

What is Hemab Therapeutics Holdings, Inc.'s market cap?: Hemab Therapeutics Holdings, Inc. (COAG) has a market capitalization of $2.3B and trades on XNAS.
Where is Hemab Therapeutics Holdings, Inc. headquartered?: Hemab Therapeutics Holdings, Inc. is headquartered in United States of America. It has been publicly traded since 2026.